Back

Volume 30 , Issue 4
July/August 2010
Pages 365-373

Histologic Evaluation of Recombinant Human Platelet-Derived Growth Factor-BB After Use in Extraction Socket Defects: A Case Series

Bradley S. McAllister, DDS, PhD/Kamran Haghighat, BDS, MS/Hari S. Prasad, BS, MDT/Michael D. Rohrer, DDS, MS

PMID: 20664838
DOI: 10.11607/prd.00.0930

Recent advancements in the arena of therapeutic molecular enhancement have shown favorable clinical findings for periodontics. However, further studies to optimize clinical outcomes using this technology are warranted. Twelve premolar extraction sockets were assigned randomly for treatment with 0.3 mg/mL recombinant human platelet-derived growth factor (rhPDGF-BB) combined with either a collagen containing anorganic deproteinized bovine bone (xenograft) or beta-tricalcium phosphate (b-TCP). Histologic evaluation of extraction socket healing was performed at 3 months. Histologic findings were similar with b-TCP and the xenograft, having 21% and 24% vital bone, respectively. The use of rhPDGF-BB with either b-TCP or a xenograft resulted in uneventful socket healing. At reentry, all implants were placed without the need for further grafting, and 100% implant success was recorded at the time of final evaluation (restoration completion). (Int J Periodontics Restorative Dent 2010;30:365–373.)

Full Text PDF File | Order Article

 

 

Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.